I G Petrochemicals Limited – Investor Presentation Summary

Key Operational Highlights

  • Total operational revenue for Q2 FY27 grew by 63% on YoY basis at ₹770 Cr, and at ₹1,395 Cr for H1 FY27, up 46% YoY.
  • Revenue from the Non-Phthalic business increased to ₹68 Cr for Q2FY27, and ₹117 Cr for H1FY27.
  • Revenue from the Export market contributed ~4% for Q2FY27.
  • Plasticizer plant commenced production on 30th September 2026.
  • Key drivers of operational performance: Improved realizations across all products.

Segment-wise Performance

Not Specified

Financial Highlights

Revenue: ₹769.7 Cr (Q2 FY27), ₹1,394.7 Cr (H1 FY27)

EBITDA: ₹144.4 Cr (Q2 FY27), ₹264.4 Cr (H1 FY27)

PAT: ₹90.4 Cr (Q2 FY27), ₹161.4 Cr (H1 FY27)

EPS: ₹29.35 (Q2 FY27), ₹52.39 (H1 FY27)

Margins: EBITDA Margin 18.8% (Q2 FY27), 19.0% (H1 FY27); PAT Margin 11.7% (Q2 FY27), 11.6% (H1 FY27)

YoY comparison: Q2 FY27 revenue up 63.2% from ₹471.6 Cr in Q2 FY26; H1 FY27 revenue up 46.4% from ₹952.5 Cr in H1 FY26

Drivers of financial performance: Improved realizations across all products

Comparison to market estimates: Not Specified

Key Risks: Not Specified

Geographical Revenue Split

Domestic vs Export Revenue: Export contributed ~4% for Q2FY27

Regional Breakdown: Not Specified

Balance Sheet Snapshot

Net Debt/Equity: Not Specified (maintained zero net debt position)

Reserves: Other Equity ₹1,436.0 Cr (Sep-26)

Current Assets/Liabilities: Current Assets ₹887.0 Cr, Current Liabilities ₹495.3 Cr (Sep-26)

Working Capital/Leverage Metrics: Not Specified

Financial Health Insights: Maintained a zero net debt position with healthy Debt-to-Equity ratio

Capex & Cash Flow Health

Capital Expenditure: Not Specified (funded largely from internal accruals)

Free Cash Flow: Not Specified

Operating Cash Flow: Net Cash from Operating Activities ₹174.2 Cr (Sep-26)

Net Debt Movement: Not Specified

Investment Rationale: Strategic investments in downstream and value-added products

Strategic & R&D Initiatives

Investments in Innovation: Plasticizer plant (production commenced September 2026), Compressed Biogas (CBG) plant (production expected December 2026), DEP debottlenecking

Expected impact on growth: Plasticizer plant and DEP debottlenecking expected to support long-term growth and expand earnings base

Strategic Rationale: Exploring adjacent downstream chemistries, diversifying revenue mix to reduce single-product dependence

Industry Trends & Business Environment

Macro/Industry Trends: Over 60% of global PAN consumption is in Asia Pacific, anticipated to expand due to increased private and government spending; Higher private and government spending on social and industrial infrastructure; Make in India push to encourage manufacturing

Impact on Company: Leading to strong and constant domestic demand for products; Increased consumption fueled by rising demand for plasticizers, paints etc.

Management Commentary & Growth Outlook

Strategic Outlook: To be a well-diversified chemicals company with leadership position in Phthalic Anhydride Industry; To consistently focus on delivering superior quality products by technological upgradation

FY Guidance: Not Specified

Market Share Targets: ~50% of India's PAN market

Risks and Opportunities: Not Specified

ESG Updates

  • ISO 9001:2015 (Quality) and ISO 14001:2015 (Environment) certified across the complex
  • Process safety management and 5S standards embedded in daily plant operations
  • Reduced greenhouse gas emissions by ~70% through steam optimisation and captive rooftop solar generation
  • Recycling of wastewater used in cooling towers
  • Set up of roof top Solar Electric Panel to reduce dependence on MSEB Grid

CSR Initiatives

  • Skill Development: Equipped 201 underserved youth with industry-aligned vocational training; Trained 150 women in industrial sewing and livelihood skills
  • Education Infrastructure: Upgraded school infrastructure across nearby communities and in Vrindavan, Uttar Pradesh
  • Environmental Sustainability: Watershed development initiative at Shirvali Group Gram Panchayat benefiting 2,800 villagers
  • Healthcare: Rehabilitation for 300+ Parkinson's patients; Menstrual health programs for 500+ adolescent girls